Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,329 INR | +1.75% | +2.80% | -2.04% |
06/05 | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
16/04 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.04% | 1.19B | |
+21.64% | 43.81B | |
+25.56% | 23.01B | |
+18.88% | 15.27B | |
+10.28% | 13.68B | |
+43.69% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.26% | 5.59B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication